Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma

Research Database / FORSCHUNGSDATENBANK

Publication 1194237 | Verified

Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma

JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)

ID	1194237
Author(s)	Adams, Heiner; Fritzsche, Florian R; Dirnhofer, Stephan; Kristiansen, Glen; Tzankov, Alexandar
Author(s) at UniBasel	Tzankov, Alexandar Dirnhofer, Stephan
Year	2010
Title	Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma
Journal	Expert opinion on therapeutic targets
Volume	14
Number	6
Pages / Article-Number	577-84
Keywords	expression, histone deacetylase, histone deacetylase inhibitor, Hodgkin's lymphoma, immunohistochemistry, tissue microarray
Abstract	HDAC inhibitors (HDI) are anti-neoplastic drugs with preliminary successful clinical applications in Hodgkin's lymphoma (HL). Systematic investigations of HDAC expression in HL, based on histology and immunohistochemistry are yet rare.
Publisher	Informa Healthcare
ISSN/ISBN	1472-8222
edoc-URL	http://edoc.unibas.ch/dok/A6004461
Full Text on edoc	No
Digital Object Identifier DOI	10.1517/14728221003796609
PubMed ID	http://www.ncbi.nlm.nih.gov/pubmed/20415600
ISI-Number	WOS:000278859500001
Document type (ISI)	Article

14/05/2024

Research Database / FORSCHUNGSDATENBANK